arrow
Back
E

EF Petricoin

George Mason University

7H-index
52Paper Count
553Citation Count
Published Papers 17
Publication Date
Laser capture microdissection
err2025-12-24
err0
PREAI
errLance A. Liotta; Thomas P. Conrads; Marissa A. Howard; Robyn P. Araujo; Emanuel F. Petricoin
errShare
errSave
Identifying breast cancer molecular phenotypes to predict response in a modern treatment landscape: Lessons from ∼1000 patients across 10 arms of the I-SPY 2 TRIAL
err2019-02-15
err0
PREAI
errWolf, D. M.; Yau, C.; Wulfkuhle, J.; Petricoin, E.; Campbell, M.; Brown-Swigart, L.; Hirst, G.; Asare, S.; Zhu, Z.; Lee, E. P.; Delson, A.; Pohlmann, P.; Hylton, N.; Liu, M. C.; Symmans, F.; DeMichele, A.; Yee, D.; Berry, D.; Esserman, L.; van 't Veer, L.
errShare
errSave
Utilizing multiomic advanced diagnostics to identify CDK4/6 inhibitor response predictors and a posttreatment multiomic signature for patients with ER+/HER2-metastatic breast cancer (SIDEOUT-3)
err2019-02-15
err0
PREAI
errAbu-Khalaf, Mm; Pierobon, M.; Denduluri, N.; Valdes-Albini, F.; Forero-Torres, A.; Clark, A.; Yung, R.; Mita, M.; Christensen, S.; Awerkamp, K.; Dunetz, B.; Murphy, R.; Hatzis, C.; Zelterman, D.; Liotta, L.; Petricoin, E.
errShare
errSave
A multi-OMIC analysis to explore the impact of actionable genomic alterations on protein pathway activation: Clinical implication for precision medicine in metastatic breast cancer
err2017-02-15
err0
PREAI
errPierobon, M.; Wong, S.; Reeded, A.; Anthony, S.; Robert, N.; Northfelt, Dw; Jahanzeb, M.; Vocila, L.; Wulfkuhle, J.; Dunetz, B.; Aldrich, J.; Byron, S.; Craig, D.; Liotta, L.; Carpten, J.; Petricoin, E. F.
errShare
errSave
Prediction of complete pathologic response to veliparib/carboplatin plus standard neoadjuvant therapy in HER2 negative breast cancer: Exploratory protein pathway marker results from the I-SPY 2 trial
err2016-02-15
err2
PREAI
errWulfkuhle, J. D.; Yau, C.; Wolf, D. M.; Gallagher, R. I.; Deng, J.; Brown-Swigart, L.; Hirst, G.; Rugo, H.; Olopade, O. I.; Esserman, L.; Berry, D.; van't Veer, L.; Petricoin, E. F.
errShare
errSave
The AKT-mTOR pathway as a potential organ-specific drug target signature of hepatic metastases from breast cancer
err2016-02-15
err0
PREAI
errPierobon, M.; Wong, S.; Reeder, A.; Anthony, S. P.; Robert, N. J.; Northfelt, D. W.; Jahanzeb, M.; Vocila, L.; Wulfkuhle, J.; Dunetz, B.; Aldrich, J.; Byron, S.; Craig, D.; Liotta, L.; Petricoin, E. F.; Carpten, J.
errShare
errSave
Acquisition of estrogen independence induces TOB1-related mechanisms supporting breast cancer cell proliferation
err2015-07-13
err27
errOAAI
errZhang, Y-W; Nasto, R. E.; Varghese, R.; Jablonski, S. A.; Serebriiskii, I. G.; Surana, R.; Calvert, V. S.; Bebu, I.; Murray, J.; Jin, L.; Johnson, M.; Riggins, R.; Ressom, H.; Petricoin, E.; Clarke, R.; Golemis, E. A.; Weiner, L. M.
errShare
errSave
Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo
err2014-05-08
err68
errOAAI
errSignore, M.; Pelacchi, F.; di Martino, S.; Runci, D.; Biffoni, M.; Giannetti, S.; Morgante, L.; De Majo, M.; Petricoin, E. F.; Stancato, L.; Larocca, L. M.; De Maria, R.; Pallini, R.; Ricci-Vitiani, L.
errShare
errSave
errShare
errSave
Protein pathway activation mapping of the I-SPY 1 biopsy specimens identifies new network focused drug targets for patients with triple negative tumors
err2012-12-01
err0
PREAI
errWulfkuhle, J. D.; Wolf, D.; Gallagher, R. I.; Yau, C.; Calvert, V.; Espina, V.; Illi, J.; Wu, Q.; Boe, M.; Van, Y.; Liotta, L. A.; van't Veer, L.; Esserman, L.; Petricoin, E. F.
errShare
errSave
Protein pathway activation mapping of I-SPY 1 biopsy specimens identifies new network focused drug targets for patients with HR+/HER2-tumors
err2012-12-01
err0
PREAI
errWulfkuhle, J. D.; Yau, C.; Gallagher, R. I.; Wolf, D.; Calvert, V.; Espina, V.; Illi, J.; Wu, Q.; Boe, M.; Van, Y.; Liotta, L. A.; van't Veer, L.; Esserman, L.; Petricoin, E. F.
errShare
errSave
Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic target
errLEUKEMIA
IF13.4
err2012-09-03
err68
errOAAI
errHartsink-Segers, S. A.; Zwaan, C. M.; Exalto, C.; Luijendijk, M. W. J.; Calvert, V. S.; Petricoin, E. F.; Evans, W. E.; Reinhardt, D.; de Haas, V.; Hedtjarn, M.; Hansen, B. R.; Koch, T.; Caron, H. N.; Pieters, R.; Den Boer, M. L.
errShare
errSave
Comparison of Community and Central Her2 Assessment on Outcome of Neoadjuvant Chemotherapy in the I-SPY Trial
err2011-12-01
err0
PREAI
errDeMichele, A.; Yau, C.; Zhu, J.; Wuhfkuhle, J.; Lenburg, M.; Buxton, M.; Davis, S.; Mies, C.; Livasy, C.; Chin, K.; Gray, J.; Carey, L.; Esserman, L.; Petricoin, E.
errShare
errSave
Bone metastasis from primary carcinomas and sarcomas: Cell signaling kinase modulation by the neuroreticular axis
errBONE
IF3.6
err2011-05-01
err0
PREAI
errChiechi, A.; Novello, C.; Magagnoli, G.; Benassi, M. S.; Picci, P.; Petricoin, E. F., III; Liotta, L. A.; Espina, V.
errShare
errSave
Importance of communication between producers and consumers of publicly available experimental data
err2005-02-15
err77
errOAAI
errLiotta, LA; Lowenthal, M; Mehta, A; Conrads, TP; Veenstra, TD; Fishman, DA; Petricoin, EF
errShare
errSave